Filgrastim biosimilar (Incepta Pharmaceuticals)

非格司亭生物类似药（Incepta Pharmaceuticals）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Incepta Pharmaceuticals)

Drug Alias NamerhG-CSF (Incepta Pharmaceuticals)非格司亭生物仿制药（Incepta Pharmaceuticals）Recombinant human granulocyte macrophage colony stimulating factor (Incepta Pharmaceuticals)重组人粒细胞刺激因子（Incepta Pharmaceuticals）

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesIncepta Pharmaceuticals Ltd

China Registration ClassN/A

Develop Information

Active CompaniesIncepta Pharmaceuticals Ltd

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02